New findings confirm Ultibro Breezhaler consistently more effective than Seretide in reducing COPD flare-ups
Ultibro Breezhaler reduced rate of all COPD exacerbations across different patient sub-groups vs Seretide in new analyses from FLAME study.
Dr Reddy's launches bupropion HCl extended-release tablets, USP (SR) in the US market
Therapeutic equivalent generic version of GSK's Wellbutrin SR.
Aptar Pharma signs development and license agreement with BD to bring a novel auto-injector to market
Compact device capable of delivering high viscosity drugs including some of the newest biologics.
Hikma launches galantamine tablets in the US
Generic equivalents to Razadyne.
Biogen’s investigational Alzheimer’s disease treatment aducanumab granted FDA Fast Track Designation
Company also provides update on new interim analysis from Phase Ib study.
Mylan invalidates third Teva Copaxone 40 mg/mL patent
US Patent and Trademark Office has ruled in favour of Mylan in its inter partes review proceeding.
I Holland to hold webinar on how to overcome tabletting challenges
Company will discuss common tabletting problems such as increasing output without capital expenditure, eliminating sticking and abrasion, minimising headwear and corrosion, all of which can be done through innovative means.
SGS opens new dedicated facility for extractables and leachables testing in Wiesbaden, Germany
The new facility will be the global Center of Excellence for Extractable Studies and Impurities Profiling, as a hub across the global network of laboratories.
New e-nose sniffs out rare progressive lung disease
The artificial nose can sniff out Pulmonary Arterial Hypertension on a person’s breath as the disease alters its signature.